Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-32169415

RESUMEN

The present study evaluated the effect of fullerene (C60) under in vitro conditions, in hippocampus homogenates from rats and on the induction of behavioral disabilities. Exposure to in vitro C60 led to an increase in the concentration of reactive oxygen species (ROS) and lipid peroxidation (LPO) of hippocampus treated with of fullerene and suspension. These results indicate that the oxidative stress caused by the exposure to C60 was in part related to an absence of an antioxidant response. In this sense, one-trial inhibitory avoidance task were performed and results showed that fullerene at 0.2 and 0.45 µm impaired the acquisition and consolidation of short and long-term memory. Further, enzymatic analysis in rat hippocampus were not significantly different, however, there was an increase in the content of LPO and ROS produced by fullerene. Overall, the results indicates that fullerene possess neurotoxic properties that impairs behavior and promotes oxidative stress.


Asunto(s)
Reacción de Prevención/efectos de los fármacos , Encéfalo/fisiopatología , Fulerenos/toxicidad , Peroxidación de Lípido , Recuerdo Mental/efectos de los fármacos , Estrés Oxidativo , Especies Reactivas de Oxígeno/metabolismo , Animales , Encéfalo/efectos de los fármacos , Ratas , Ratas Wistar
2.
Beilstein J Org Chem ; 13: 694-702, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28503204

RESUMEN

The use of sonochemistry is described in the organocatalytic enamine-azide [3 + 2] cycloaddition between 1,3-diketones and aryl azidophenyl selenides. These sonochemically promoted reactions were found to be amenable to a range of 1,3-diketones or aryl azidophenyl selenides, providing an efficient access to new ((arylselanyl)phenyl-1H-1,2,3-triazol-4-yl)ketones in good to excellent yields and short reaction times. In addition, this protocol was extended to ß-keto esters, ß-keto amides and α-cyano ketones. Selanyltriazoyl carboxylates, carboxamides and carbonitriles were synthesized in high yields at short times of reaction under very mild reaction conditions.

3.
Neurosci Lett ; 651: 182-187, 2017 06 09.
Artículo en Inglés | MEDLINE | ID: mdl-28432028

RESUMEN

This study investigates Se-phenyl-thiazolidine-4-carboselenoate (Se-PTC) protective activity against oxidative and behavioral stress in the model of mania induced by ouabain (OUA) in male rats. The compound used was Se-PTC (50mg/kg) and the positive control LiCl (45mg/kg) was administered for intragastric route (i.g.) 30min prior to administration of OUA (10-5M). OUA was dissolved in artificial cerebrospinal fluid (aCSF) and administered at the 5µl through an intracerebroventricular (i.c.v) cannula. The pretreatment with Se-PTC was effective in preventing the increase in locomotor activity induced by OUA, however the positive control LiCl is capable to block crossing augmentation induced by OUA. Na+/K+-ATPase activity was significantly reduced in OUA group and the Se-PTC to normalize Na+/K+-ATPase activity. Pretreatment with Se-PTC protect against the increase in catalase activity and thiobarbituric acid reactive species (TBARS) content in the brain caused by OUA. Therefore, Se-PTC is effective against OUA-induced hyperactivity and alterations in brain oxidative status of rats.


Asunto(s)
Conducta Animal/efectos de los fármacos , Trastorno Bipolar/tratamiento farmacológico , Trastorno Bipolar/metabolismo , Encéfalo/efectos de los fármacos , Fármacos Neuroprotectores/administración & dosificación , Compuestos de Organoselenio/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , Tiazolidinas/administración & dosificación , Animales , Trastorno Bipolar/inducido químicamente , Encéfalo/metabolismo , Modelos Animales de Enfermedad , Locomoción/efectos de los fármacos , Masculino , Ouabaína/administración & dosificación , Ratas Wistar
4.
Ultrason Sonochem ; 34: 107-114, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27773224

RESUMEN

We described herein the use of sonochemistry in the organocatalytic enamine-azide [3+2] cycloadditions of ß-oxo-amides with a range of substituted aryl azides. These sonochemical promoted reactions were found to be amenable to a range of ß-oxo amides or aryl azides, providing an efficient access to new N-aryl-1,2,3-triazoyl carboxamides in good to excellent yields and short times of reaction.

5.
J Org Chem ; 81(22): 11472-11476, 2016 11 18.
Artículo en Inglés | MEDLINE | ID: mdl-27731643

RESUMEN

We described herein our results on the silver-catalyzed synthesis of diaryl selenides via a cross-coupling reaction of diaryl diselenides with aryl boronic acids. The methodology is tolerant to electron-donor and electron-withdrawing groups at the substrates and the desired products were obtained in good to excellent yields.

6.
Org Lett ; 17(24): 6206-9, 2015 Dec 18.
Artículo en Inglés | MEDLINE | ID: mdl-26632867

RESUMEN

Organocatalytic enamine-azide [3 + 2] cycloadditions between ß-keto sulfones and aryl azides can be performed at room temperature in good to excellent yields of products in the presence of catalytic amounts of pyrrolidine (5 mol %). The proposed organocatalytic methodology was found to be applicable to ß-keto arylsulfones containing a range of substituents. A wide variety of aryl azides also work. Basically, this constitutes a remarkably efficient protocol for the synthesis of novel 1,2,3-triazole compounds.

7.
Life Sci ; 93(9-11): 393-400, 2013 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-23911670

RESUMEN

AIMS: The study investigated the antidepressant-like effect and acute toxicity of 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole (Se-TZ), an organoselenium-containing heterocycle compound in mice. MAIN METHODS: The antidepressant-like effect of Se-TZ (1-50mg/kg) and its mechanism of action, was analyzed in the tail suspension test (TST) in male C57BL/6J mice. Additionally, the levels of the monoamines and their metabolites in cerebral cortex and hippocampus were analyzed by high-performance liquid chromatography. To investigate the potential acute toxicity caused by Se-TZ, the mice received a single oral dose of Se-TZ (1-50mg/kg), and after 72h were performed the assays. KEY FINDINGS: The Se-TZ (5-50mg/kg) significantly reduced immobility time in TST without altering locomotor and exploratory activities. The antidepressant-like effect of Se-TZ (25mg/kg) in the TST was prevented by pre-treatment of mice with SCH23390, sulpiride and methysergide, but not with prazosin, yohimbine and propranolol. Se-TZ, increased monoamine neurotransmitters dopamine and serotonin levels in the cerebral cortex and hippocampus, whereas norepinephrine turnover was not changed. This study also demonstrated that the Se-TZ, did not cause the acute toxicity in biochemical markers hepatic and renal investigated. The results evidenced that exposure to Se-TZ caused a significant increase in the catalase (CAT) activity in the cerebral cortex and hippocampus, however the glutathione S-transferase (GST) activity increased only in the cerebral cortex. SIGNIFICANCE: These results suggest that Se-TZ demonstrated antidepressant-like effect, mediated via the central dopaminergic and serotoninergic neurotransmitter systems which may be of interest as a therapeutic agent for the treatment of depressive disorders.


Asunto(s)
Antidepresivos/farmacología , Depresión/tratamiento farmacológico , Dopamina/metabolismo , Compuestos de Organoselenio/farmacología , Serotonina/metabolismo , Triazoles/farmacología , Animales , Antidepresivos/administración & dosificación , Antidepresivos/toxicidad , Catalasa/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Cromatografía Líquida de Alta Presión , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Glutatión Transferasa/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Norepinefrina/metabolismo , Compuestos de Organoselenio/administración & dosificación , Compuestos de Organoselenio/toxicidad , Factores de Tiempo , Pruebas de Toxicidad Aguda , Triazoles/administración & dosificación , Triazoles/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA